VLT-015 in Patients With Schizophrenia

Exclusion criteria

• ✕. The presence of contraindications to the use of VLT-015:
• ✕. Patients requiring medication or other concomitant therapies listed in the unacceptable concomitant therapy section;
• ✕. The presence of prostatic hyperplasia or glaucoma in patients;
• ✕. Diseases of the bone marrow in history;
• ✕. Active tuberculosis, cystic fibrosis, systemic connective tissue diseases, oncological processes of any localization;
• ✕. Severe, decompensated or unstable somatic diseases (any diseases or conditions that threaten the patient's life or worsen the prognosis patient, and also make it impossible to conduct a clinical trial);
• ✕. Alcoholism and drug addiction at the present time, or in history;
• ✕. Lack of patient willingness to cooperate, non-compliance of the patient;